Benoxaprofen
| CAS No. | 51234-28-7 |
|---|---|
| MDL No. | MFCD00866099 |
| MF | C16H12ClNO3 |
| MW | 301.72 |
| InChI Key | MITFXPHMIHQXPI-UHFFFAOYSA-N |
| CAS No. | 51234-28-7 |
|---|---|
| MDL No. | MFCD00866099 |
| MF | C16H12ClNO3 |
| MW | 301.72 |
| InChI Key | MITFXPHMIHQXPI-UHFFFAOYSA-N |
| Pack Size | Purity | Price | Availability | Action |
|---|---|---|---|---|
| 1 mg | 99% | $20 | In Stock | |
| 25 mg | 99% | $104 | In Stock | |
| 50 mg | 99% | $174 | In Stock | |
| 100 mg | 99% | $293 | In Stock | |
| 250 mg | 99% | $554 | In Stock | |
| 1 g | 99% | $1765 | In Stock | |
| Custom synthesis and bulk supply options are available upon request. | ||||
Benoxaprofen is a monocarboxylic acid with a propionic acid structure substituted at position 2 by a 2-(4-chlorophenyl)-1,3-benzoxazol-5-yl group. It was a non-steroidal anti-inflammatory drug until 1982, when it was withdrawn due to adverse effects including liver necrosis, photosensitivity, and carcinogenicity in animals. It functions as a non-steroidal anti-inflammatory drug, an arachidonate 5-lipoxygenase inhibitor, an antipyretic, a non-narcotic analgesic, a protein kinase C agonist, a hepatotoxic and nephrotoxic agent, and an antipsoriatic. It belongs to 1,3-benzoxazoles, monocarboxylic acids, and monochlorobenzenes, and is functionally related to propionic acid.
| CAS No. | 51234-28-7 |
|---|---|
| Product Name | Benoxaprofen |